C. diff and H. pylori Detection Analyzer Lease and Reagents CRDAMC, Fort Hood, TX

SOL #: PR0012407898Sources Sought

Overview

Buyer

DEPT OF DEFENSE
Dept Of The Army
W40M MRC0 WEST
JBSA FT SAM HOUSTON, TX, 78234-4504, United States

Place of Performance

Fort Hood, TX

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (6550)

Set Aside

No set aside specified

Timeline

1
Posted
Apr 29, 2026
2
Response Deadline
May 6, 2026, 9:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Medical Readiness Contracting Office-West (MRCO-W) is conducting market research via a Sources Sought notice for a C. diff and H. pylori Detection Analyzer Lease and Reagents at Carl R. Darnall Army Medical Center (CRDAMC), Fort Hood, TX. This requirement is for an analyzer and associated reagents on a Cost Per Test (CPT) lease basis. Responses are due May 6, 2026.

Scope of Work

The requirement is for an analyzer capable of detecting C. difficile bacteria Type A and Type B and H. pylori stool antigen (HpSA). Key capabilities include:

  • Detection of C. difficile toxin antigens and H. pylori stool antigen.
  • Delivery of analyzer and reagents no later than July 1, 2026, for validation.
  • Dry testing capability.
  • Space constraint: 5" x 5" x 5".
  • Vendor must provide maintenance support at CRDAMC.
  • Reagent quantities: 150 tests for C. difficile A & B, 1500 tests for H. pylori stool antigen.

Contract & Timeline

  • Type: Sources Sought (Market Research)
  • Anticipated Contract Type: Firm Fixed-Price (competitive basis)
  • Projected Duration: 12-month base period + four (4) 12-month option periods, commencing October 1, 2026.
  • NAICS: 325413 In-Vitro Diagnostic Substance Manufacturing (Size Standard: 1,250 employees)
  • PSC: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
  • Response Due: May 6, 2026, by 4:00 p.m. CDT
  • Published: April 29, 2026

Set-Aside & Eligibility

This requirement may be set-aside for small businesses (in full or in part) or procured through full and open competition. All small business set-aside categories will be considered. Interested parties must be registered in SAM.gov.

Submission Requirements

Interested parties should submit a Statement of Capability (up to 5 pages) via email to MAJ Elliott Boice (elliott.r.boice2.mil@health.mil). The submission must include:

  • Offeror's name, address, point of contact, phone, and email.
  • Interest in providing a proposal/quote.
  • Capability to meet personnel requirements.
  • Capability to perform a contract of this magnitude and complexity, specifically providing the analyzer and reagents on a CPT basis.
  • Documentation of appropriate products.
  • Business size and type (e.g., 8(a), HUBZone, WOSB, SDVOSB, Large Business).

Additional Notes

This is for informational purposes only and does not constitute a solicitation or commitment to award a contract. Responses will inform the acquisition strategy.

People

Points of Contact

Files

Files

No files attached to this opportunity

Versions

Version 1Viewing
Sources Sought
Posted: Apr 29, 2026
C. diff and H. pylori Detection Analyzer Lease and Reagents CRDAMC, Fort Hood, TX | GovScope